According to Zhitong Finance App, Xilong Science (002584.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 4.307 billion yuan, up 27.90% year on year; net profit attributable to shareholders of listed companies was 394.13 million yuan, turning a year-on-year loss into profit; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 46.642 million yuan, an increase of 16.39% year on year; basic earnings per share were 0.0673 yuan.

During the reporting period, the company's overall business scale continued to expand, the quality of operations improved steadily, and both operating income and net profit after deducting non-recurring profit and loss achieved steady growth. The increase in revenue from the lithium iron phosphate cathode materials business is the main reason for the increase in the company's revenue. Electronic chemicals and generic reagents form the company's main source of profit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.